Cyanoindole derivatives as highly selective dopamine D4 receptor partial agonists:: Solid-phase synthesis, binding assays, and functional experiments

被引:67
作者
Hübner, H [1 ]
Kraxner, J [1 ]
Gmeiner, P [1 ]
机构
[1] Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Med Chem, D-91052 Erlangen, Germany
关键词
D O I
10.1021/jm0009989
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Traceless linking of diethoxymethyl (DEM)-protected 5- and 6-cyanoindoles and subsequent incorporation of phenylpiperazine derivatives led to the 2- and 3-piperazinylmethyl-substituted cyanoindoles 3a-m. Dopamine receptor binding studies on the final products 3a-m clearly indicated strong and selective recognition of the D-4 subtype which is known as a promising target for the treatment of neuropsychiatric disorders. The most interesting binding properties were observed for the 2-aminomethyl-5-cyanoindoles FAUC 299 (3f) and FAUC 316 (3j) (K-i = 0.52 and 1.0 nM, respectively) when the fluoro derivative 3j proved extraordinary selectivity over D-1, D-2long, D-2short, and D-9 (>8600). To determine ligand efficacy, mitogenesis experiments were performed indicating partial agonist effects for the test compounds 3fj (35% and 30%, when compared to the full agonist quinpirole).
引用
收藏
页码:4563 / 4569
页数:7
相关论文
共 24 条
[1]   MODULATION OF INTRACELLULAR CYCLIC-AMP LEVELS BY DIFFERENT HUMAN DOPAMINE D4 RECEPTOR VARIANTS [J].
ASGHARI, V ;
SANYAL, S ;
BUCHWALDT, S ;
PATERSON, A ;
JOVANOVIC, V ;
VANTOL, HHM .
JOURNAL OF NEUROCHEMISTRY, 1995, 65 (03) :1157-1165
[2]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[3]  
CHIO CL, 1994, MOL PHARMACOL, V45, P51
[4]   Synthesis and SAR of 2- and 3-substituted 7-azaindoles as potential dopamine D4 ligands [J].
Curtis, NR ;
Kulagowski, JJ ;
Leeson, PD ;
Ridgill, MP ;
Emms, F ;
Freedman, SB ;
Patel, S ;
Patel, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (04) :585-588
[5]  
DANN O, 1986, LIEBIGS ANN CHEM, P438
[6]   NGD 94-1 as an agonist at human recombinant dopamine D4.4 receptors expressed in HEK293 cells [J].
Gazi, L ;
Sommer, B ;
Nozulak, J ;
Schoeffter, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 372 (03) :R9-R10
[7]   The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor [J].
Gazi, L ;
Bobirnac, I ;
Danzeisen, M ;
Schüpbach, E ;
Bruinvels, AT ;
Geisse, S ;
Sommer, B ;
Hoyer, D ;
Tricklebank, M ;
Schoeffter, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (05) :889-896
[8]   Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells [J].
Gazi, L ;
Bobirnac, I ;
Danzeisen, M ;
Schüpbach, E ;
Langenegger, D ;
Sommer, B ;
Hoyer, D ;
Tricklebank, M ;
Schoeffter, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (03) :613-620
[9]  
Hartman D S, 1997, Prog Drug Res, V48, P173
[10]   2,2-Dicyanovinyl as a nonaromatic aryl bioisostere:: Synthesis, binding experiments and SAR studies of highly selective dopamine D4 receptor ligands [J].
Haubmann, C ;
Hübner, H ;
Gmeiner, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (14) :1969-1972